13 Recruiting Studies Using Alectinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Alectinib
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
📍 University of Colorado Cancer Center — Aurora, Colorado
Cancer
View Study & Checklist ➔Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
📍 Northwest Cancer Specialists, P.C. — Tigard, Oregon
Non-Small Cell Lung Cancer
View Study & Checklist ➔An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
📍 Clinica Adventista Belgrano — Ciudad Autonoma Buenos Aires,
NSCLC
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
📍 UC Davis — Sacramento, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
📍 Western Regional Medical Center at Cancer Treatment Centers of America — Goodyear, Arizona
Solid Tumors
View Study & Checklist ➔A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
📍 Lucile Packard Children's Hospital — Palo Alto, California
ALK Fusion-positive Solid or CNS Tumors
View Study & Checklist ➔A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
📍 Massachusetts general Hospital — Boston, Massachusetts
Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
📍 Memorial Sloan Kettering Basking Ridge (LimitedProtocol Activities) — Basking Ridge, New Jersey
Anaplastic Lymphoma Kinase
View Study & Checklist ➔Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
📍 Stanford University — Stanford, California
Lung Cancer
View Study & Checklist ➔Alectinib Pharmacokinetic in Patients With NSCLC
📍 Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional de Cancerología — Mexico City, Mexico City
Non-small Cell Lung Cancer Stage IIIB
View Study & Checklist ➔A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
📍 Palo Verde Hematology Oncology — Glendale, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔